Global stocks falter as Gilead halts trial of potential coronavirus treatment – CNN

Business News

  1. Global stocks falter as Gilead halts trial of potential coronavirus treatment  CNN
  2. Data on Gilead’s remdesivir show no benefit for coronavirus patients  STAT
  3. Gilead halted after medication Remdesivir flopped in coronavirus trial  CNBC Television
  4. Dow pares some gains after reports say Gilead’s remdesivir shows disappointing results  MarketWatch
  5. Here’s How Global Market Are Panning Out As Gilead’s Remdesivir Disappoints | Bazaar Morning Call  CNBC-TV18
  6. View Full Coverage on Google News

Source: Business News

/by